Evidence map›Paper›PMID 41998011›Full record

ArticleScientific reports2026

Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese population.

Anh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, Lanh Sy Nguyen, Huong Lan Nguyen, Nghia Chinh Quach, Thau Manh Cao, Hanh Thi Nguyen, Xuan Thanh Thai, Anh Tuan Luong and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Anh Gia Pham *Department of Oncology, Viet-Duc University Hospital, Hanoi, Vietnam. phamgiaanh@gmail.com.
An Vu-Khanh Le *Department of General Planning, Viet-Duc University Hospital, Hanoi, Vietnam.
Yen Thi-Hai Pham *UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lanh Sy Nguyen *Department of Pathology, Viet-Duc University Hospital, Hanoi, Vietnam.
Huong Lan NguyenDepartment of Radiology and Diagnostic Imaging, Viet-Duc University Hospital, Hanoi, Vietnam.
Nghia Chinh QuachBlood Transfusion Center, Viet-Duc University Hospital, Hanoi, Vietnam.
Thau Manh CaoDepartment of Oncology, Viet-Duc University Hospital, Hanoi, Vietnam.
Hanh Thi NguyenDepartment of Oncology, Viet-Duc University Hospital, Hanoi, Vietnam.
Xuan Thanh ThaiDepartment of Oncology, Viet-Duc University Hospital, Hanoi, Vietnam.
Anh Tuan LuongBlood Transfusion Center, Viet-Duc University Hospital, Hanoi, Vietnam.
Thuy Thi PhamSchool of Information and Communication Technology, Hanoi University of Science and Technology, Hanoi, Vietnam.
Hai Duy VuSchool of Electronics and Electrical Engineering, Hanoi University of Science and Technology, Hanoi, Vietnam.
Hai Thi-Thanh TranSchool of Electronics and Electrical Engineering, Hanoi University of Science and Technology, Hanoi, Vietnam.
Lan Thi LeSchool of Electronics and Electrical Engineering, Hanoi University of Science and Technology, Hanoi, Vietnam.
Hai VuSchool of Electronics and Electrical Engineering, Hanoi University of Science and Technology, Hanoi, Vietnam.
Giang Binh TranDepartment of Emergency Abdominal Surgery, Viet-Duc University Hospital, Hanoi, Vietnam.
Hung N LuuUPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. hluu2@houstonmethodist.org.

Funding

Translational Research Training in Cancer Prevention and ControlT32CA186873 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kathryn H. Schmitz, Jian-Min Yuan · 2014 to 2026
$2.7M
NIH HHS T32CA186873VinGroup Innovation Foundation-VINIF VINIF.2020.DA.06
6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) comprises a spectrum of liver diseases from simple steatosis, metabolic dysfunction-associated steatohepatitis (MASH) which progresses to fibrosis and compensated cirrhosis. Worldwide, MASLD significantly contributes to the rising incidence of liver cancer. Lille is known about its predictors in Asian population and particularly among Vietnamese. We determined the predictors of MASLD in Vietnamese population using a hospital-based case-control study of 100 MASLD patients and 119 healthy controls. Unconditional logistic regression model was used to calculate odds ratios (ORs) and respective 95% confidence intervals (CIs) for MASLD in relation to potential predictors. Overall, body mass index (BMI) (OR

Indexed as

Fatty LiverAdultBody Mass IndexCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsVietnamhepatocellular carcinomaMASLDNAFLDPredictorsVietnam

Identifiers

PMID41998011
PMCPMC13247050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.